Bayer | BAYN - Loan Capital

Stock Price
45.80
Daily Change
0.99 2.20%
Monthly
19.46%
Yearly
118.67%
Q1 Forecast
43.25

Bayer reported EUR32.71B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Air Liquide EUR 9.68B 1.28B Jun/2025
Akzo Nobel EUR 3.67B 13M Dec/2025
Alcon AG USD 4.59B 73M Sep/2025
Arkema EUR 4.11B 470M Sep/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
BASF EUR 18.93B 32M Sep/2025
Bayer EUR 32.71B 1B Sep/2025
Beiersdorf EUR 132M 20M Jun/2025
Corteva USD 1.69B 1000K Sep/2025
Covestro EUR 2.08B 35M Sep/2025
Essilor EUR 9.37B 431M Jun/2025
Fresenius EUR 10.8B 1.49B Sep/2025
Fresenius Medical Care EUR 9.34B 3.01B Sep/2025
Genmab DKK 126M 6M Sep/2025
Givaudan CHF 4.29B 175M Jun/2024
GlaxoSmithKline GBP 14.71B 186M Dec/2025
GRIFOLS EUR 9.09B 1.64B Sep/2025
Henkel EUR 2.01B 40M Jun/2025
Hikma Pharmaceutical USD 798M 191M Jun/2025
Johnson Matthey GBP 1.34B 3M Dec/2025
Linde USD 18.59B 1.11B Sep/2025
Lonza CHF 4.24B 602M Dec/2024
Merck EUR 10.45B 4.15B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Nutrien USD 10.81B 49M Sep/2025
Philips EUR 7.24B 55M Sep/2025
PPG Industries USD 6.6B 698M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
SAP EUR 6.02B 68M Dec/2025
Solvay EUR 2.05B 2M Sep/2025
UCB EUR 2.82B 146M Jun/2025
Umicore EUR 2.25B 62.6M Jun/2025
Vinci EUR 41.93B 11.14B Dec/2025